Molecular and cellular understanding of psoriasis pathogenesis has evolved considerably
over the last 30 years beginning in the early 1980s when psoriasis was thought to be a skin …

The response of psoriasis to antibodies targeting the interleukin ( IL )‐23/ IL ‐17A pathway
suggests a prominent role of T‐helper type‐17 (Th17) cells in this disease. We examined the …

Background Psoriasis severity categories have been important tools for clinicians to use in
treatment decisions as well as to determine eligibility criteria for clinical studies. However, …

BACKGROUND: Etanercept is well tolerated and effective in moderate to severe plaque
psoriasis. However, effectiveness and safety data beyond 2.5 years have not been reported. …

Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long
roundtable discussion with the primary purpose to discuss the treatment goals of …

Rosacea is a common and chronic skin disorder characterized by persistent redness on the
convex surfaces of the face in addition to a spectrum of facial clinical features including …

Background Little is known about the impact of long-term use of immunosuppressive agents
on immune response. Objectives Assess the impact of continuous maintenance …

As the most commonly sexually transmitted disease worldwide, human papillomavirus (HPV)
infections are associated with significant morbidity and mortality. HPV infections most …

Background: Atopic dermatitis is a chronic, relapsing and remitting disease that can be
difficult to treat despite a recently approved biologic therapy targeting IL-4/IL-13 receptor. Oral …

… Marc Bourcier has served as consultant for AbbVie, Amgen, Eli-Lilly, Janssen, and Novartis.
Wayne Gulliver has served as advisor/consultant and received research grants from AbbVie…